Betamethasone
Betamethasone is a topical corticosteroid used on the skin to relieve inflammation and itching from corticosteroid-responsive skin conditions, and, in spray form, to treat mild to moderate plaque psoriasis.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 83 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Betamethasone is a prescription skin steroid that calms red, swollen, itchy skin conditions and, as a spray, mild to moderate plaque psoriasis; it has been around since the early 1960s, is available as a generic, and its augmented versions are among the strongest topical steroids. Short courses are usually well tolerated, and brief burning, stinging or itching where it goes on is the most common complaint. The risk is overuse, which can thin the skin and let steroid soak in to suppress your body's stress-hormone system (the HPA axis), so use the smallest area for the shortest time and stop once the skin is under control.
Clinical pearls
- Skip the face, groin and underarms unless your prescriber says otherwise, because thin skin there absorbs more steroid.
- Don't cover treated skin with bandages or plastic wrap unless told to, since covering pushes much more steroid in.
- Augmented products are usually limited to two weeks with a weekly cap on how much you use, so don't refill indefinitely.
- Report any vision changes promptly, since skin steroids can raise the risk of cataracts and glaucoma.
Patient information guide A plain-language walkthrough of Betamethasone, written from its FDA label.
What Betamethasone is used for
▾
Betamethasone comes in several skin products with somewhat different uses.
- Betamethasone dipropionate gel, ointment, cream and lotion, including Diprolene Ointment, relieve inflammation and itching from corticosteroid-responsive skin conditions.
- Betamethasone valerate cream, ointment and lotion are used for the same purpose.
- Betamethasone valerate foam is for these skin conditions on the scalp.
- Betamethasone dipropionate spray, including Sernivo, treats mild to moderate plaque psoriasis in adults 18 and older.
How Betamethasone works
▾
Corticosteroids play a role in cell signaling, immune function, inflammation and protein regulation. How the spray works in psoriasis is not precisely known.
Betamethasone dosage
▾
Betamethasone is applied to the skin only. Most dipropionate products are used once or twice daily, while the spray is used twice daily. Betamethasone valerate products may be used more often, and the foam goes on the scalp twice daily.
- Stop when the skin is under control.
- Don't use occlusive dressings unless your doctor directs it.
- Follow your prescriber's directions and the product label.
Dosing details from the FDA-approved label
From the Betamethasone prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Betamethasone dipropionate lotion (augmented), 0.05% (topical)
- Apply a few drops to the affected skin areas once or twice daily and massage lightly until the lotion disappears
- Discontinue therapy when control is achieved
- Limit therapy to no more than 2 consecutive weeks
- Maximum: No more than 50 mL per week
- Not for use with occlusive dressings unless directed by a physician; avoid use on the face, groin, or axillae, or if skin atrophy is present
- Betamethasone dipropionate ointment (augmented), 0.05% / Augmented Betamethasone Dipropionate Ointment / DIPROLENE Ointment (topical)
- Apply a thin film to the affected skin areas once or twice daily
- Discontinue therapy when control is achieved
- Limit therapy to no more than 2 consecutive weeks
- Maximum: No more than 50 g per week
- Not for use with occlusive dressings unless directed by a physician; avoid use on the face, groin, or axillae, or if skin atrophy is present
- Betamethasone dipropionate cream USP (augmented), 0.05% / betamethasone dipropionate cream (augmented) (topical)
- Apply a thin film to the affected skin areas once or twice daily
- Discontinue therapy when control is achieved
- Maximum: No more than 50 g per week
- Not for use with occlusive dressings unless directed by a physician; avoid use on the face, groin, or axillae, or if skin atrophy is present
- Betamethasone dipropionate spray (topical)
- Shake well before use
- Apply to the affected skin areas twice daily and rub in gently
- Use for up to 4 weeks
- Treatment beyond 4 weeks is not recommended
- Discontinue when control is achieved
- Do not use if atrophy is present at the treatment site; do not bandage, cover, or wrap the treated area unless directed by a physician; avoid face, scalp, axilla, groin, or other intertriginous areas
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION Apply a few drops of betamethasone dipropionate lotion (augmented), 0.05% to the affected skin areas once or twice daily and massage lightly until the lotion disappears. Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Betamethasone dipropionate lotion (augmented), 0.05% is a super-high-potency topical corticosteroid. Treatment with betamethasone dipropionate lotion (augmented), 0.05% should be limited to 2 consecutive weeks and amounts should not exceed 50 mL per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis [see Warnings and Precautions (5.1) ] . Betamethasone dipropionate lotion (augmented), 0.05% should not be used with occlusive dressings unless directed by a physician. Avoid use on the face, groin, or axillae, or if skin atrophy is present at the treatment site. Avoid contact with eyes. Wash hands after each application. Betamethasone dipropionate lotion (augmented), 0.05% is for topical use only. It is not for oral, ophthalmic, or intravaginal use. • Apply a few drops to the affected skin areas once or twice daily and massage lightly until the lotion disappears.( 2 ) • Discontinue therapy when control is achieved. ( 2 ) • Limit therapy to no more than 2 consecutive weeks. ( 2 ) • Use no more than 50 mL per week. ( 2 ) • Do not use with occlusive dressings unless directed by a physician. ( 2 ) • Avoid use on the face, groin, or axillae, or if skin atrophy is present at the treatment site. ( 2 ) • Not for oral, ophthalmic, or intravaginal use. ( 2 )
Read the full Dosage and Administration section on DailyMed →
Betamethasone side effects
▾
Most side effects occur where the product is applied.
Common side effects
- Itching at the application site
- Burning or stinging
- Pain at the application site
- Thinning of the skin (atrophy)
- Dryness or irritation
- Acne-like breakouts
When to get medical help
- Call your doctor if you have vision changes. Topical steroids may raise the risk of cataracts and glaucoma.
- Call your doctor if your skin gets worse or irritated, or you suspect an allergic reaction to the product.
- Report signs of too much steroid absorption, such as Cushing's syndrome or high blood sugar. These are rare.
- Tell your doctor if your skin hasn't improved within 2 weeks (for products that carry this instruction).
Less common effects include dryness, irritation, stretch marks, acne-like breakouts and lighter skin patches. Call your doctor about vision changes or signs of an allergic reaction.
Betamethasone warnings and precautions
▾
- Absorption through the skin can suppress the body's stress-hormone system (HPA axis). This is usually reversible.
- Risk rises with strong products, large areas, long use, covered skin, liver failure and young age.
- Topical steroids may increase the risk of cataracts and glaucoma. Keep products out of your eyes.
- Rarely, Cushing's syndrome and high blood sugar can occur after prolonged use of very large amounts.
- Stop use if irritation develops, and tell your doctor.
Before taking Betamethasone
▾
- Don't use it if you're allergic to betamethasone, other corticosteroids, or any ingredient in the product.
- Check age limits. Many augmented products are for ages 13 and older, and the spray is for adults 18 and older.
- Tell your doctor if you are pregnant or breastfeeding. Use the smallest area for the shortest time.
- Avoid the face, groin and underarms unless directed, and avoid skin with atrophy.
- Tell your doctor if you have liver problems.
What Betamethasone does in the body
▾
In healthy volunteers, betamethasone dipropionate spray tested as mid-range in strength compared with other topical steroids. In a study of adults with extensive psoriasis, some people showed HPA axis suppression after 15 days of twice-daily use. Follow-up tests in those checked were normal.
How your body processes Betamethasone
▾
Topical steroids are absorbed through normal skin. Absorption depends on the product vehicle, the condition of the skin barrier and the use of occlusive dressings. Inflamed or diseased skin absorbs more. In the spray study, most people had no measurable drug in their blood.
How to store Betamethasone
▾
Store at 20° to 25°C (68° to 77°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Betamethasone: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Betamethasone — the kind of thing our pharmacy team would talk through with you at the counter.
What is betamethasone used for?
▾
How do I apply it?
▾
How long can I use it?
▾
What side effects should I expect?
▾
Can I put it on my face or cover it with a bandage?
▾
Is it safe in pregnancy or for children?
▾
Is Betamethasone available over the counter?
▾
When was Betamethasone first available?
▾
Who makes Betamethasone?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Betamethasone on HelloPharmacist
Betamethasone forms and strengths (how it comes)
Betamethasone is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Betamethasone inactive ingredients by manufacturer.
Topical cream, ointment or gel
How this form is used
- Diprolene Ointment relieves inflammation and itching from corticosteroid-responsive skin conditions in patients 13 and older.
- Betamethasone dipropionate gel (augmented) is used for the same purpose and is not recommended under age 12.
- Diprolene Ointment is applied as a thin film once or twice daily.
- Diprolene Ointment is for the skin only, not for the mouth, eyes or vagina.
- Diprolene Ointment should not be used with occlusive dressings unless a physician directs it.
- Betamethasone dipropionate gel (augmented) should not be used beyond two consecutive weeks.
Inhaler
Topical spray
How this form is used
- Sernivo Spray treats mild to moderate plaque psoriasis in adults 18 and older.
- Betamethasone dipropionate spray has the same use in adults 18 and older.
- Sernivo Spray should be shaken well, applied twice daily and rubbed in gently.
- Sernivo Spray should be used for up to 4 weeks only.
- Sernivo Spray should not be used on the face, scalp, underarms, groin or other skin-fold areas.
- Sernivo Spray should not be covered or bandaged unless a physician directs it.
Betamethasone on the U.S. market: products, makers and brands
How Betamethasone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
29 companies list 79 Betamethasone product records with the FDA, mostly as topical cream, ointment or gel, inhaler, topical spray; the earliest marketing or approval year on record is 1961. Brand names on the directory include Luxiq, Betavet, Sernivo and 2 more; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (44) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Betamethasone is used (Medicaid data)
A general measure of how commonly Betamethasone is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Betamethasone is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Betamethasone prescribed? Of the 1,601 medications we measure, Betamethasone ranks #288 by Medicaid prescriptions — more than 82% of them.
Utilization by Betamethasone product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
betamethasone 0.5 MG/ML Topical Cream Most dispensed
Summed across the 12 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 238920
betamethasone 1 MG/ML Topical Cream
Summed across the 6 of 23 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197407
betamethasone 0.0005 MG/MG Topical Ointment
Summed across the 10 of 21 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197405
betamethasone 0.001 MG/MG Topical Ointment
Summed across the 4 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197409
Augmented betamethasone 0.5 MG/ML Topical Cream
Summed across the 4 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848176
betamethasone 0.5 MG/ML Topical Lotion
Summed across the 3 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 240209
Augmented betamethasone 0.0005 MG/MG Topical Ointment
Summed across the 10 of 25 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848180
betamethasone 1 MG/ML Topical Lotion
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197408
Augmented betamethasone 0.5 MG/ML Topical Lotion
Summed across the 4 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848178
betamethasone valerate 1.2 MG/ML Topical Foam
Summed across the 6 of 14 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1244634
Augmented betamethasone 0.0005 MG/MG Topical Gel
Summed across the 2 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848208
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Betamethasone, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 62 of 171 listed Betamethasone NDCs with Medicaid activity.
Compare Betamethasone products
A representative set of FDA-listed product records for Betamethasone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhaler | ||||
| 1.2 mg/g | Topical | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 1.2 mg/g | Topical | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 1.2 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd | ANDA | View NDC → |
| 1.2 mg/g | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 1.2 mg/g | Topical | Xiromed, LLC. | ANDA | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 0.5 mg/g | Topical | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | A-S Medication Solutions × 7 listings | ANDA | View NDC → |
| 1 mg/g | Topical | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 1.2 mg/g | Topical | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | Actavis Pharma, Inc. × 3 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Asclemed USA, Inc | ANDA | View NDC → |
| 0.5 mg/g | Topical | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Bryant Ranch Prepack × 7 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Burel Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.5 mg/g | Topical | Cosette Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Cosette Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1.2 mg/g | Topical | Cosette Pharmaceuticals, Inc. | NDA | View NDC → |
| 1.2 mg/g | Topical | Cosette Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC × 2 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.5 mg/mL | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC × 2 listings | NDA | View NDC → |
| 1 mg/mL | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | NDA | View NDC → |
| 0.5 mg/mL | Topical | Encube Ethicals, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 0.5 mg/g | Topical | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Northstar Rx LLC. | ANDA | View NDC → |
| 0.5 mg/g | Topical | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | NuCare Pharmaceuticals,Inc. | ANDA | View NDC → |
| 1.2 mg/g | Topical | NuCare Pharmaceuticals,Inc. | NDA | View NDC → |
| 0.5 mg/g | Topical | Organon LLC | NDA | View NDC → |
| 0.5 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd × 3 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| 0.5 mg/g | Topical | Preferred Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Preferred Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1 mg/g | Topical | Preferred Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | Proficient Rx LP | ANDA | View NDC → |
| 1 mg/g | Topical | Proficient Rx LP | NDA | View NDC → |
| 1.2 mg/g | Topical | Proficient Rx LP | ANDA | View NDC → |
| 0.5 mg/g | Topical | Redpharm Drug | ANDA | View NDC → |
| 0.5 mg/g | Topical | Remedyrepack Inc. | NDA | View NDC → |
| 0.5 mg/g | Topical | Sun Pharmaceutical Industries, Inc. × 3 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 1 mg/g | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Viona Pharmaceuticals Inc | ANDA | View NDC → |
| 0.5 mg/g | Topical | Zydus Lifesciences Limited × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 💊Topical spray | ||||
| 0.5 mg/g | Topical | Primus Pharmaceuticals, Inc. | NDA | View NDC → |
| 0.5 mg/g | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
Showing 79 of 79 products — FDA National Drug Code Directory. See every product, package size and price: browse all 79 Betamethasone NDCs →
Betamethasone side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Betamethasone — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Betamethasone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Betamethasone FDA approval history
How Betamethasone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Betamethasone recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list one Betamethasone recall since July 2021. It is no longer listed as ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Betamethasone Dipropionate Cream USP, 0.05%, 45 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0055-46 Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that i… FDA record D-1028-2022 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 1514 13 dose forms · 22 strengths
-
Dose form (SCDF) Disintegrating Oral Tablet RxCUI 379265No current FDA listingClinical drug / strength (SCD) 0.5 MGRxCUI 105389 -
Dose form (SCDF) Injectable Solution RxCUI 371049No current FDA listingClinical drug / strength (SCD) 4 MG/MLRxCUI 308718 -
Dose form (SCDF) Injectable Suspension RxCUI 378340No current FDA listingClinical drug / strength (SCD) 6 MG/MLRxCUI 1660745 -
Dose form (SCDF) Ophthalmic Ointment RxCUI 376457No current FDA listingClinical drug / strength (SCD) 0.001 MG/MGRxCUI 249596 -
Dose form (SCDF) Oral Solution RxCUI 371053No current FDA listingClinical drug / strength (SCD) 0.12 MG/MLRxCUI 670084 -
Dose form (SCDF) Oral Tablet RxCUI 371056No current FDA listingClinical drug / strength (SCD) 0.5 MGRxCUI 2452580.6 MGRxCUI 308709 -
Dose form (SCDF) Topical Cream RxCUI 377613In current FDA listingsClinical drug / strength (SCD) Augmented betamethasone 0.5 MG/MLRxCUI 8481760.5 MG/MLRxCUI 2389201 MG/MLRxCUI 197407 -
Dose form (SCDF) Topical Foam RxCUI 384499In current FDA listingsClinical drug / strength (SCD) valerate 1.2 MG/MLRxCUI 1244634 -
Dose form (SCDF) Topical Gel RxCUI 377967In current FDA listingsClinical drug / strength (SCD) Augmented betamethasone 0.0005 MG/MGRxCUI 8482080.0005 MG/MGRxCUI 240571 -
Dose form (SCDF) Topical Lotion RxCUI 377614In current FDA listingsClinical drug / strength (SCD) Augmented betamethasone 0.5 MG/MLRxCUI 8481780.5 MG/MLRxCUI 2402091 MG/MLRxCUI 197408 -
Dose form (SCDF) Topical Ointment RxCUI 374614In current FDA listingsClinical drug / strength (SCD) Augmented betamethasone 0.0005 MG/MGRxCUI 8481800.0005 MG/MGRxCUI 1974050.001 MG/MGRxCUI 1974090.005 MG/MGRxCUI 895257 -
Dose form (SCDF) Topical Solution RxCUI 371057No current FDA listingClinical drug / strength (SCD) 1 MG/MLRxCUI 250861 -
Dose form (SCDF) Topical Spray RxCUI 377311In current FDA listingsClinical drug / strength (SCD) 0.5 MG/MLRxCUI 1738536
Look up RxCUI 1514 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Betamethasone supply and shortage status
Whether Betamethasone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Betamethasone costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Cream · Topical | 0.5 mg/g | $0.371–$0.465 per gram | NDC details & price history |
| Cream · Topical | 1 mg/g | $0.348–$0.415 per gram | NDC details & price history |
| Cream · Topical | 1.2 mg/g | $0.348–$0.415 per gram | NDC details & price history |
| Ointment · Topical | 0.5 mg/g | $0.349–$0.460 per gram | NDC details & price history |
| Ointment · Topical | 1 mg/g | $0.492–$0.614 per gram | NDC details & price history |
| Ointment · Topical | 1.2 mg/g | $0.492–$0.614 per gram | NDC details & price history |
| Ointment, Augmented · Topical | 0.5 mg/g | $0.535–$0.588 per gram | NDC details & price history |
| Lotion · Topical | 0.5 mg/mL | $0.292 per mL | NDC details & price history |
| Lotion · Topical | 0.5 mg/g | $0.292 per mL | NDC details & price history |
| Lotion · Topical | 1 mg/mL | $0.452 per mL | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Betamethasone brand names
Betamethasone is sold under 5 brand names in the FDA directory — Luxiq, Betavet, Sernivo, Del-Beta and others. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Betamethasone: manufacturers and labelers
29 companies list Betamethasone products with the FDA. By number of product records, the largest are A-S Medication Solutions, E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC, Bryant Ranch Prepack. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 5 more on the FDA NDC directory.
Betamethasone drug class (RxNorm)
Betamethasone belongs to the Corticosteroid class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Betamethasone page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Primus Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →